Raymond James & Associates trimmed its stake in The Chemours Company (NYSE:CC) by 18.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 58,152 shares of the specialty chemicals company’s stock after selling 13,118 shares during the period. Raymond James & […]
